602 related articles for article (PubMed ID: 27185298)
1. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
3. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
Hanafy AS; Farid RM; ElGamal SS
Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
[TBL] [Abstract][Full Text] [Related]
4. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
5. Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease.
Wong LR; Ho PC
J Pharm Pharmacol; 2018 Jan; 70(1):59-69. PubMed ID: 29034965
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle transport across in vitro olfactory cell monolayers.
Gartziandia O; Egusquiaguirre SP; Bianco J; Pedraz JL; Igartua M; Hernandez RM; Préat V; Beloqui A
Int J Pharm; 2016 Feb; 499(1-2):81-89. PubMed ID: 26721725
[TBL] [Abstract][Full Text] [Related]
7. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
[TBL] [Abstract][Full Text] [Related]
8. Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies.
El-Zaafarany GM; Soliman ME; Mansour S; Awad GA
Int J Pharm; 2016 Apr; 503(1-2):127-40. PubMed ID: 26924357
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
10. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
11. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A
Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
13. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
Girotra P; Singh SK; Kumar G
Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
[TBL] [Abstract][Full Text] [Related]
14. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
[TBL] [Abstract][Full Text] [Related]
15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
16. Nose-to-brain delivery of tacrine.
Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
[TBL] [Abstract][Full Text] [Related]
17. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
[TBL] [Abstract][Full Text] [Related]
19. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.
Alam MI; Baboota S; Ahuja A; Ali M; Ali J; Sahni JK; Bhatnagar A
Int J Pharm; 2014 Aug; 470(1-2):99-106. PubMed ID: 24810241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
